This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Hk Inno.n Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Myeongjoong Kim: Innovator in Protein Kinase Inhibition
Introduction
Myeongjoong Kim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit protein kinases. His work is crucial in addressing various diseases, including cancer and autoimmune disorders.
Latest Patents
Myeongjoong Kim holds a patent for a heterocyclic compound that acts as a protein kinase inhibitor. This invention provides a novel compound with protein kinase inhibition activity, along with its stereoisomers and pharmaceutically acceptable salts. The compounds developed by Kim are effective in preventing or treating diseases related to protein kinases, such as cancer, autoimmune diseases, neurological disorders, and infections.
Career Highlights
Myeongjoong Kim is associated with Hk Inno.n Corporation, where he continues to innovate in the field of drug development. His expertise in medicinal chemistry has positioned him as a key player in the pharmaceutical industry.
Collaborations
Myeongjoong Kim collaborates with talented coworkers, including Hyuk Woo Lee and Ha Na Yu. Their combined efforts contribute to advancing research and development in their field.
Conclusion
Myeongjoong Kim's work in developing protein kinase inhibitors represents a significant advancement in medical science. His contributions are vital for the future of treatments for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile